PhD, BSc (Hons)
Postdoctoral Research Scientist
Multi-level omics analysis in a murine model of dystrophin loss and therapeutic restoration.
Roberts TC. et al, (2015), Hum Mol Genet, 24, 6756 - 6768
The physiological consequences of different levels of dystrophin following antisense based exon-skipping in the mdx mouse
Muses S. et al, (2015), NEUROMUSCULAR DISORDERS, 25, S312 - S313
Identification of novel therapy-responsive protein biomarkers for Duchenne muscular dystrophy by aptamer-based serum proteomics
Coenen-Stass A. et al, (2015), NEUROMUSCULAR DISORDERS, 25, S251 - S252
An overview of the clinical application of antisense oligonucleotides for RNA-targeting therapies.
McClorey G. and Wood MJ., (2015), Curr Opin Pharmacol, 24, 52 - 58
Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies.
Rouillon J. et al, (2015), Hum Mol Genet, 24, 4916 - 4932